ArticleEuropean journal of nutrition2025
Capsosiphon fulvescens glycopeptides restore synaptic plasticity and mitigate cognitive decline via calcineurin regulation in aged hippocampus.
Article in European journal of nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeAge-related cognitive decline and synaptic loss are associated with alterations in hippocampal synaptic protein phosphorylation and signaling pathways. Natural compounds from marine sources, such as Capsosiphon fulvescens glycopeptides (Cf-tPep), have shown potential neuroprotective properties. This study aimed to investigate the effects of trypsinized glycopeptides from C. fulvescens on synaptic protein phosphorylation and cognitive function in aging hippocampal neurons and rats.
methodsThe research employed both in vitro and in vivo experimental models to evaluate the impact of Cf-tPep on aged hippocampal neurons and cognitive function in rats. Primary hippocampal neurons from rats were cultured for 49 days to model aging. Synaptic protein expression and phosphorylation were analyzed through Western blotting, immunoprecipitation, and double-immunofluorescence. In vivo, aged rats received Cf-tPep via hippocampal microinjection using osmotic pumps. Cognitive function was assessed using the Morris water maze test.
resultsCf-tPep treatment restored phosphorylation levels of synaptic proteins, including PSD95 (S295) and GluN2B (Y1472), in aged neurons. This effect was mediated through inhibition of the calcineurin-STEP signaling pathway and activation of CaMKII-ERK1/2 signaling, enhancing synaptic plasticity and reducing neuronal senescence. In aged rats, Cf-tPep improved spatial learning and memory retention by modulating synaptic protein phosphorylation.
conclusionTrypsinized glycopeptides from C. fulvescens show promise as a therapeutic agent for alleviating age-related cognitive decline through regulation of synaptic signaling pathways. These findings suggest their potential for promoting brain health in the elderly.
Indexed as
Identifiers
41051592What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.